Connect with us

Health

Delayed 2nd Pfizer/BioNTech shot boosts antibodies in elderly; COVID-19 obesity risk higher for men – KSL.com

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness…

Published

on

Article feature image
ADVERTISEMENT

WASHINGTON (Reuters) The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Delaying second Pfizer/BioNTech dose boosts antibodies in elderly
Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine beyond the originally recommended three-week gap used by the companies in clinical trials appears to induce a stronger antibody response in the elderly, UK researchers…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
US coronavirus: Nearly every new Covid-19 death is now entirely preventable, CDC director says – msnNOW
FDA to add warning about rare heart inflammation to Pfizer and Moderna vaccines – The Guardian
Article feature image
Coronavirus update San Antonio, June 23: Metro Health reports 7-day average of 105 COVID-19 cases, 4 new deaths – KSAT San Antonio